Considering the administration of Desferral supplementary and Vitamin C on the ferritin levels of Quid 19 patients

Phase 3

Recruiting

• Conditions: COVID-19.; U07.1 COVID posetive; U07.1

• Registration Number: IRCT20190121042444N3
• Lead Sponsor: Shahid Beheshti University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 13 July 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 78

Inclusion Criteria

Get infected with a viral infection COVID-19
High serum ferritin levels
Increased inflammatory factor in the blood

Exclusion Criteria

Patients with renal insufficiency
Consumption of desferal supplementary in them is contraindicated

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
CRP rate. Timepoint: Before the start of the intervention and the third day after the intervention. Method of measurement: Based on serum surface measurement.;CRP rate. Timepoint: Before the start of the intervention and the third day after the intervention. Method of measurement: Based on serum surface measurement.